Health & Medicine World stem cells & regenerative medicine congress, london, may 22, 2013

1. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced Cell Technology Inc”, or “the Company”) salient business characteristics.…

Technology Act corporate-presentation---may-2013---wscrm---print-version

1. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced Cell Technology Inc”, or “the Company”) salient businesscharacteristics.The…